Royal Philips (NYSE:PHG) said today it launched the artificial intelligence powered HealthSuite Insights analytics software suite designed for the curation and analysis of healthcare data.
The launch includes the Amsterdam-based company’s Insights Marketplace, which allows users access to curated AI-based assets from Philips and others through its own private ecosystem.
AI-based tools available through the newly launched HealthSuite Insights cover fields including diagnostic imaging solutions, patient monitoring solutions, oncology and genomics, Philips said.
The marketplace will initially supply only assets from Philips, with plans to add other medically validated Philips assets later this year, and assets from third parties at a later date.
“The quality of your AI is only as good as the quality of the data you feed into it. We have designed HealthSuite Insights to be used by the people who work with patient data on a daily basis and have the contextual understanding; including doctors, clinicians and hospital managers. With the HealthSuite Insights platform, we give them the ability to bring all the relevant patient information together, curate the data and use the power of AI to support precision diagnosis, personalized therapy, early intervention and greater hospital efficiency,” Philips chief innovation & strategy officer Jeroen Tas said in a prepared statement.
Last month, Philips announced plans to shutter manufacturing operations at a Cleveland plant that makes computed tomography scanners as part of a $600 million R&D initiative.
